The Role of Apathy in Glycemic Control
| Status: | Archived |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2009 |
| End Date: | June 2012 |
In spite of several new medications and insulins for the control of blood sugars in patients
with diabetes, a large number of patients do not have good control. This likely due to
inability to carry out regular activities and self-care behaviors such as taking meds
regularly, keeping a good diet, exercise etc. This inability to carry out self care
lifestyle changes may be due to a condition called apathy. Apathy is a lack of motivation
and persistence. In this study we will attempt to treat apathy with a medication called
methylphenidate for 6 months and see if blood sugar/diabetes control improves.
The incidence of diabetes in the US is at epidemic proportions. A large number of diabetes
patients in the VA system have uncontrolled diabetes with high HbA1c. The inability to carry
out important self-care behaviors such as measuring blood sugars regularly, following diet,
exercise and medication programs may be due to apathy. Apathy is the lack of motivation,
persistence and novelty. We have found this to be very prevalent in the VA diabetes
population. We now do a randomized placebo controlled trial to see if treatment of apathy
with methylphenidate will improve glycemic control in patients with A1c >8. Treatment will
be for 6 months. The primary end point is HbA1c.
We found this trial at
1
site
Click here to add this to my saved trials
